Get Your Personalized Supplement StackSupplement Stack Quiz

Graviola Proprietary Blend

Also known as: Graviola, Soursop, Annona muricata

Overview

Graviola, scientifically known as *Annona muricata*, is a tropical plant traditionally used for its medicinal properties. It is rich in bioactive compounds, including annonaceous acetogenins, alkaloids, flavonoids, and phenolic compounds like rutin, kaempferol, and quercetin. Graviola is primarily used for its antioxidant, anti-inflammatory, and potential anticancer effects. It is available in various forms, including leaf extracts, bark extracts, and whole plant extracts. While research shows promise, particularly in in vitro and animal studies, more rigorous human trials are needed to confirm its efficacy and safety. The plant is sourced from tropical regions and has been a part of traditional medicine practices for centuries. Its potential benefits extend to managing oxidative stress and supporting overall well-being, but it should be used with caution and under medical supervision due to limited human data and potential side effects.

Benefits

Graviola extracts have demonstrated potential in inhibiting cancer cell growth and inducing apoptosis in various cancer types, including breast, prostate, and pancreatic cancers, primarily in in vitro and animal studies. These effects are attributed to its bioactive compounds, which can interfere with cellular metabolism and cell cycle regulation. Additionally, graviola exhibits antioxidant properties, which may help in managing oxidative stress-related conditions. Some evidence suggests anti-diabetic effects by influencing lipid metabolism and hepatic glucose levels, but this is mainly observed in animal models. While these findings are promising, human trials are limited, and the specific effect sizes and clinical significance in humans are not well-documented. More research is needed to confirm these benefits and establish appropriate dosages for human use.

How it works

Graviola's mechanism of action is attributed to its bioactive compounds, such as annonaceous acetogenins, which can inhibit cellular metabolism, downregulate genes involved in glycolysis and hypoxia, and induce apoptosis in cancer cells. These compounds interact with various body systems by modulating antioxidant pathways and potentially affecting glucose metabolism. Specifically, graviola targets proteins involved in cell cycle regulation and apoptosis, disrupting cancer cell proliferation. Its antioxidant properties help neutralize free radicals, reducing oxidative stress. The exact molecular mechanisms are still under investigation, but the current understanding suggests a multi-faceted approach involving multiple biological pathways.

Side effects

While graviola is generally considered safe in traditional use, long-term safety data are limited, and potential side effects should be considered. Common side effects are not well-documented due to the lack of extensive human studies. However, potential neurotoxicity has been raised as a concern, although not extensively studied. Graviola may interact with chemotherapy drugs due to its anticancer properties, potentially affecting their efficacy. It is contraindicated in pregnancy and breastfeeding due to a lack of safety data. Caution is advised in patients with Parkinson's disease due to potential neurotoxic effects. Due to limited data, it is essential to use graviola under medical supervision, especially for individuals with pre-existing conditions or those taking other medications.

Dosage

Due to limited human studies, specific dosage guidelines for graviola are not well-established. Animal studies have used doses around 100-200 mg/kg body weight, but these cannot be directly translated to human dosages. Optimal dosage ranges vary based on the specific preparation (leaf extracts, bark extracts, or whole plant extracts) and intended use. The maximum safe dose is not established, and caution is advised due to potential neurotoxicity. There are no specific timing recommendations available. Given the lack of clear guidelines and potential risks, it is crucial to consult with a healthcare professional before using graviola to determine an appropriate and safe dosage.

FAQs

How should Graviola be used?

Graviola should be used under medical supervision due to potential interactions and side effects. Consult a healthcare professional before starting any regimen.

Is Graviola safe for long-term use?

While traditionally used, long-term safety and efficacy in humans are not well-studied. Exercise caution and consult with a healthcare provider.

What are the expected results from using Graviola?

Results are variable; it may support antioxidant and anticancer effects, but human data are limited. Do not rely on it as a sole treatment for any condition.

Is Graviola a cure for cancer?

No, Graviola is often mistakenly believed to be a cure for cancer without sufficient evidence. It should not be used as a replacement for conventional cancer treatments.

Research Sources

https://pmc.ncbi.nlm.nih.gov/articles/PMC9865140/ – Zeweil et al. (2023) found that graviola leaf extract attenuated DMBA-induced breast cancer in rats by enhancing apoptosis and antioxidant pathways. This study suggests potential benefits for breast cancer, but it is limited by its animal model and the need for human trials to confirm these findings.
https://pubmed.ncbi.nlm.nih.gov/22475682/ – Torres et al. (2012) demonstrated that graviola extract inhibited pancreatic cancer cell growth and metastasis in vitro and in vivo. This preclinical study provides promising evidence, but it lacks human data, highlighting the need for clinical trials to validate these results.
https://pmc.ncbi.nlm.nih.gov/articles/PMC6091294/ – Coria-Téllez et al. provided a comprehensive review highlighting graviola's anticancer properties across various cancer types. The review emphasizes the need for more rigorous human studies to confirm these effects, as current data are primarily from preclinical studies.
https://www.science.gov/topicpages/g/guava+plant+psidium – This link refers to guava plant psidium, which is not graviola. Therefore, it is not relevant to the research summary for graviola and will not be summarized.
http://repo.polkesraya.ac.id/2536/1/ICASH4_Abstract%20Book_FIX.pdf – This link leads to an abstract book. Without specific information on graviola from this source, a detailed summary cannot be provided. Further investigation into the book's contents would be needed to extract relevant information.